Baltimore is known for being home to companies such as Under Armour Inc. (NYSE:UA) and McCormick & Co. (NYSE:MKC) and, of course, HBO’s “The Wire.” But a new survey suggests Baltimore also is a destination for high-salaried technology workers.
Baltimore in 2013 had the second-highest average salary for employees in the technology sector, according to jobs database Dice.com. The 2013 average salary for tech workers was $97,588 — a 0.3 percent decrease from the year before.
ROCK SPRING VENTURES,A LEADING EARLY-STAGE LIFE SCIENCE VENTURE CAPITAL FUND, IS NOW EPIDAREX CAPITAL
Our new name is inspired by Epidaurus, the home of ancient Greece’s first hospital and the temple of the Greek God of Medicine. It reflects our focus on innovation in the healthcare sector and our commitment to investing in young life science and health technology companies. Visit www.epidarex.com.
STAY TUNED FOR A NUMBER OF EXCITING ANNOUNCEMENTS THROUGHOUT THE COMING YEAR…
Johnson & Johnson ($JNJ) is the latest Big Pharma company that has vowed to open its clinical trial data vaults to the public. Going a step further than previous efforts, it’s enlisting the help of Yale University to manage data requests.
Under an agreement with the Yale School of Medicine, the school’s Open Data Access (YODA) Project will serve as an independent body to oversee requests from investigators and physicians looking to access anonymized clinical trial data from J&J’s Janssen. YODA, not J&J, will review each request and make final decisions on data sharing. Members of the YODA team will select and appoint an independent external panel of non-Janssen experts to help in some cases to assess requests.
Emergent BioSolutions Inc. announced today the closing of its previously announced offering of 2.875% Convertible Senior Notes due 2021 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933. Emergent issued $250 million aggregate principal amount of its notes, which includes the additional $35 million principal amount of notes purchased by the initial purchasers under the exercise of the option granted to them by the company.
Emergent intends to use a majority of the net proceeds from the offering to finance the acquisition of Cangene Corporation, announced in December 2013. The company intends to use any remaining net proceeds from the offering for general corporate purposes, which may include repaying outstanding indebtedness under its existing credit facility.
Please join us for the 7th Annual Health Information Technology (HIT) Day of advocacy in Annapolis. Our agenda is focused on ‘HIT in Action! Consumer Engagement’ where we will showcase the perspectives of consumers using HIT today as well as their future hopes, concerns, and the value derived from accessing one’s health information as the healthcare industry transforms.
We are finally hosting the FLC’s National Meeting (Federal Laboratory Consortium) here in Montgomery County! This program gives our local companies easy access to federal labs from across the country. As part of a triple opportunity, the FLC is helping to sponsor the Post Doc Conference (April 24) – and MEDA (Maryland Economic Development Association) has chosen tech transfer as their theme for this year’s Annual Conference (April 27-29). Three great programs all within one week!
We really want to spread the word about our area’s terrific connectivity with the federal labs, and would appreciate your assistance. Attached is the flyer, the program is posted on the DED calendar, and you can access more information about the agenda and registration at www.federallabs.org. Note: The biggest opportunity for our companies is on April 23rd which is Industry Day – so a one-day registration may work well for some businesses.
Noble Life Sciences (Gaithersburg, MD), in collaboration with IBT Bioservices (Gaithersburg, MD), announces a newly optimized cotton rat model for preclinical studies of RSV (respiratory syncytial virus) therapies and vaccines. The companies jointly developed the model of RSV infection in the cotton rat and demonstrated its use to evaluate the efficacy of test compounds in RSV challenge studies.
Cotton rats are the gold standard for preclinical development of drugs and vaccines for RSV. The cotton rat gained importance for RSV studies because the permissiveness of cotton rats to infection with human RSV surpasses that of mice by more than 100-fold and because the model replicates several characteristic features of the human disease. Moreover, the predictive quality of the model is so high that treatments for severe disease advanced to clinical trials based on the results of efficacy and safety studies using cotton rats without the need for testing in primates.
I was in Washington D.C. today at the State of the Net conference, listening to conversations about internet governance, Bitcoin, broadband metrics and privacy. And despite the fact that this an event about technology I’ve never felt so out of place.
It’s not just because everyone around me is wearing a suit. Here a few differences between political conferences and tech conferences; some of which are humorous, but others that are worth learning from.
The Mid-Atlantic area is full of outstanding leaders and innovative companies, but only a chosen few will receive a coveted TCM Industry Award. Our winners develop technologies that save lives, keep the country safe, and consistently perform beyond expectations. Play a part in helping us choose our next class of winners! Nominate now!
The nominations process is easier than ever this year. We will be accepting nominations in 7 categories from any company or individual that has done business in the Mid-Atlantic region during 2013, and you don’t have to be a TCM member to submit.
There are 7 prestigious award categories including:
Visit our secure online site to nominate a firm or individual. It only takes a few minutes! The deadline to submit is Friday, February 28, 2014.
Remember, talking about a great leader or remarkable company won’t make a difference, but nominating them will! Nominate now!
The effort to focus the post O’Malley era in Maryland on developing private sector businesses and jobs got a big boost Friday from the unprecedented joint agenda of House Speaker Michael E. Busch and Senate President Thomas V. Mike Miller. It’s encouraging that the two top leaders in the General Assembly are both focused on the issue at the same time that most of the candidates for governor next year are talking about the same thing and private sector advocacy groups like the Greater Baltimore Committee are pursuing similar efforts. But what is more intriguing is the nature of the ideas Messrs. Busch and Miller are putting forward.
Too often, the debate about whether Maryland is business friendly goes no farther than a glance at the Tax Foundation’s reports on the state and local tax structure, as if the only choices are a Maryland heavily oriented toward government or one that radically slashes taxes and regulation. The truth is that there are other models for success, and the one that best suits Maryland’s strengths is a strategy that leverages our great advantages in intellectual capital to produce jobs in high-tech fields like biotechnology and cyber security. The Miller/Busch proposal recognizes that through tax credits to attract superstars from the private sector to academia, build the cyber security industry and encourage business formation in the areas directly surrounding institutions like Johns Hopkins and the University of Maryland.
